Alzheimer's Disease therapy with antibody against oligomeric Abeta peptides

A novel, proprietary antibody for the therapy and/or diagnosis of Alzheimer's Disease was developed by scientists at the University Medical Center Gottingen.

http://www.innovations-report.com/html/reports/technology_offerings/alzheimer_s_disease_therapy_antibody_oligomeric_212521.html